| abstract |
The present invention relates to compounds of formula (I)n n n Formula In n n n n n n n Wheren n n R 1 is optionally substituted phenyl, morpholinyl, pyrerazinyl, pyrrolidinyl, piperidinyl, or thiomorpholinyl, 1-oxo-thiomorpholinyl or 1,1-dioxothiomorphopoly Neal.n n n These compounds have good affinity for the NK-1 receptor and are therefore suitable for modulating or treating diseases associated with this receptor. |